{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:14:09Z","timestamp":1754162049994,"version":"3.41.2"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In-stent restenosis is a common complication after percutaneous coronary intervention. The purpose of the current study is to look for associations of genetic variation in adrenergic beta-2 receptor (<jats:italic toggle=\"yes\">ADR\u03b22<\/jats:italic>), and cyclin-dependent kinase inhibitor 1B (<jats:italic toggle=\"yes\">CDKN1B<\/jats:italic>) genes in patients diagnosed with in-stent restenosis (ISR) after percutaneous coronary intervention in the Egyptians.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Polymorphisms in <jats:italic toggle=\"yes\">ADR\u03b22<\/jats:italic> and <jats:italic toggle=\"yes\">CDKN1B<\/jats:italic> were determined using PCR-restriction fragment length polymorphism in 200 Egyptian patients who underwent coronary angioplasty and stent placement of whom 100 patients developed ISR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We found that the GG genotype of <jats:italic toggle=\"yes\">ADR\u03b22<\/jats:italic> and CC genotype of <jats:italic toggle=\"yes\">CDKN1B<\/jats:italic> were more likely to develop restenosis after stenting (odds ratio = 3.7 and 3.2; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001, respectively). Our study considered that male sex, diabetes, obesity, bare-metal stents type of implanted stents, longer stents, GG genotype of <jats:italic toggle=\"yes\">ADR\u03b22<\/jats:italic>, and CC genotype of <jats:italic toggle=\"yes\">CDK1B<\/jats:italic> were significant independent predictors for ISR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>our results indicate that <jats:italic toggle=\"yes\">ADR\u03b22<\/jats:italic> (rs1042713) and <jats:italic toggle=\"yes\">CDKN1B<\/jats:italic> (rs36228499) could be associated with the development of ISR in Egyptians.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001123","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T12:14:39Z","timestamp":1642594479000},"page":"277-283","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Single-nucleotide polymorphism of ADR\u03b22 and CDKN1B genes in Egyptian patients with coronary artery in-stent restenosis"],"prefix":"10.1097","volume":"33","author":[{"given":"Tarek A.","family":"Abdelaziz","sequence":"first","affiliation":[{"name":"Cardiology Department, Faculty of Medicine, Zagazig University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randa H.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa M.","family":"Gad","sequence":"additional","affiliation":[{"name":"Cardiology Department, Faculty of Medicine, Zagazig University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed G.","family":"Ghareeb","sequence":"additional","affiliation":[{"name":"Cardiology Department, Faculty of Medicine, Zagazig University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara F.","family":"Saadawy","sequence":"additional","affiliation":[{"name":"Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nrcardio.2011.132","article-title":"Restenosis after PCI. Part 1: pathophysiology and risk factors.","volume":"9","author":"Jukema","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.niox.2013.09.004","article-title":"Nitric oxide, a protective molecule in the cardiovascular system.","volume":"35","author":"Lei","year":"2013","journal-title":"Nitric Oxide"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1165\/ajrcmb\/8.3.334","article-title":"Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects.","volume":"8","author":"Reihsaus","year":"1993","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jaci.2005.11.012","article-title":"Molecular mechanisms of \u03b22-adrenergic receptor function, response, and regulation.","volume":"117","author":"Johnson","year":"2006","journal-title":"J Allergy Clin. Immunol"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1023\/A:1021477021102","article-title":"Beta-adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics.","volume":"19","author":"Johnson","year":"2002","journal-title":"Pharm Res"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCINTERVENTIONS.110.957332","article-title":"Vascular smooth muscle cell proliferation in restenosis.","volume":"4","author":"Marx","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCULATIONAHA.108.842179","article-title":"p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity.","volume":"120","author":"van Tiel","year":"2009","journal-title":"Circulation"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1172\/JCI119874","article-title":"Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.","volume":"100","author":"Martinez","year":"1997","journal-title":"J Clin Invest"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1741-7007-2-5","article-title":"A single-nucleotide polymorphism in the human p27kip1 gene (-838C>A) affects basal promoter activity and the risk of myocardial infarction.","volume":"2","author":"Gonz\u00e1lez","year":"2004","journal-title":"BMC Biol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/oxfordjournals.aje.a121626","article-title":"Synergy and antagonism in cause-effect relationship.","volume":"99","author":"Rothman","year":"1974","journal-title":"Am J Epidemiol"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0735-1097(97)00450-6","article-title":"In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.","volume":"31","author":"Kornowski","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12872-020-01798-2","article-title":"The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1164\/ajrccm.158.3.9801035","article-title":"beta2-Adrenergic receptor haplotypes in mild, moderate and fatal\/near fatal asthma.","volume":"158","author":"Weir","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/CIRCULATIONAHA.105.536268","article-title":"Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.","volume":"112","author":"Monraats","year":"2005","journal-title":"Circulation"},{"key":"R16-20250729","first-page":"537","article-title":"beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals.","volume":"139","author":"Hoit","year":"2000","journal-title":"Am Heart J"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.RES.87.1.39","article-title":"beta(2)-adrenoceptors activate nitric oxide synthase in human platelets.","volume":"87","author":"Queen","year":"2000","journal-title":"Circ Res"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"832821","DOI":"10.4061\/2010\/832821","article-title":"Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.","volume":"2010","author":"Masuo","year":"2010","journal-title":"Int J Hypertens"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-3806(99)00078-4","article-title":"Changes in the expression of alpha(2)-adrenergic receptor subtypes during maturation of neuronal cells from fetal pig superior cervical ganglia.","volume":"116","author":"Fraeyman","year":"1999","journal-title":"Brain Res Dev Brain Res"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1254\/jjp.89.327","article-title":"Nitric oxide synthase gene therapy for cardiovascular disease.","volume":"89","author":"Chen","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fimmu.2013.00111","article-title":"Role of arginase in vessel wall remodeling.","volume":"4","author":"Durante","year":"2013","journal-title":"Front Immunol"},{"key":"R22-20250729","first-page":"86","article-title":"Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry.","volume":"21","author":"Pesarini","year":"2009","journal-title":"J Invasive Cardiol"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1677\/ERC-09-0016","article-title":"Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.","volume":"17","author":"Landa","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jvs.2016.12.113","article-title":"A single nucleotide polymorphism of cyclin-dependent kinase inhibitor 1B (p27Kip1) associated with human vein graft failure affects growth of human venous adventitial cells but not smooth muscle cells.","volume":"67","author":"Kenagy","year":"2018","journal-title":"J Vasc Surg"},{"key":"R25-20250729","first-page":"804","article-title":"Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of angiographic and late-term clinical results.","volume":"76","author":"Brown","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"e18312","DOI":"10.1097\/MD.0000000000018312","article-title":"The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention.","volume":"98","author":"Tang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"e25484","DOI":"10.1097\/MD.0000000000025484","article-title":"Risk factors of in-stent restenosis in patients with diabetes mellitus after percutaneous coronary intervention: a protocol for systematic review and meta-analysis.","volume":"100","author":"Li","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11154-010-9135-3","article-title":"Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.","volume":"11","author":"Aronson","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3389\/fendo.2020.00591","article-title":"Endothelial dysfunction in diabetic retinopathy.","volume":"11","author":"Gui","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/01.CIR.0000131898.18849.65","article-title":"Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial.","volume":"109","author":"Singh","year":"2004","journal-title":"Circulation"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00043798-199502000-00008","article-title":"Restenosis after transluminal coronary angioplasty: a risk factor analysis.","volume":"2","author":"G\u00fcrlek","year":"1995","journal-title":"J Cardiovasc Risk"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1515\/CCLM.2006.155","article-title":"Lack of association between alpha2B-adrenergic receptor polymorphism and risk of restenosis following coronary angioplasty and stent implantation\u2013preliminary report.","volume":"44","author":"Manolis","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0002-8703(03)00085-1","article-title":"Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus.","volume":"145","author":"Mazeika","year":"2003","journal-title":"Am Heart J"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.","volume":"331","author":"Fischman","year":"1994","journal-title":"N Engl J Med"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"E1150","DOI":"10.21037\/jtd.2016.10.93","article-title":"Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment.","volume":"8","author":"Buccheri","year":"2016","journal-title":"J Thorac Dis"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/hrt.2005.061622","article-title":"Drug eluting stents: an updated meta-analysis of randomised controlled trials.","volume":"92","author":"Roiron","year":"2006","journal-title":"Heart"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2459\/JCM.0b013e32833e58e4","article-title":"Long-term outcomes with cobalt-chromium bare-metal vs. drug-eluting stents: the REgistro regionale AngiopLastiche dell\u2019Emilia-Romagna registry.","volume":"12","author":"Manari","year":"2011","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCINTERVENTIONS.110.946939","article-title":"Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry.","volume":"3","author":"Stolker","year":"2010","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:05:56Z","timestamp":1753812356000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001123","relation":{},"ISSN":["0954-6928"],"issn-type":[{"type":"print","value":"0954-6928"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}